Ampio Pharmaceuticals (AMPE) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Ampio Pharmaceuticals, Inc. has announced the successful completion of its recent nonclinical studies in a press release dated February 14, 2024. The company emphasizes that the information provided should not be considered part of the formal financial filings required by the SEC, but it serves to keep investors informed about its latest research developments.
For further insights into AMPE stock, check out TipRanks’ Stock Analysis page.
